i on MSN8h
The study to find out why some brains are more susceptible to Parkinson’s than others
One of the major breakthroughs over the last couple of years has been a potential new diagnostic test for Parkinson’s – a ...
Business Wire21h
U.S. Food and Drug Administration Approves Bristol Myers Squibb’s COBENFY™ (xanomeline and trospium chloride), a First-In-Class Muscarinic Agonist for the Treatment of ...
U.S. FDA Approves Bristol Myers Squibb’s COBENFY, a First-In-Class Muscarinic Agonist for the Treatment of Schizophrenia in Adults ...
Las Vegas Sun12h
They keep finding — and losing — a granddaughter in the grip of addiction
Jackie seemed to be on the right path in her 20s; she was smart and successful, working for several years as a manager at high-end restaurants. But in her late teens, she began ...
Psychology Today22h
How False Memories Can Ensnare Us in a Cycle of Abuse
False memory manipulation is a tactic used to control abuse victims and foster dependence. Recognizing how memory functions ...
New drug for schizophrenics has experts excited
Experts expressed enthusiasm Friday after US health regulators approved the first new form of treatment for schizophrenia in ...
Psychology Today1h
4 Plant Compounds That Transform the Brain
Plant compounds like caffeine, L-theanine, tryptamines, and polyphenols can alter brain function, potentially influencing ...
health.wusf.usf.edu20h
A new kind of drug for schizophrenia promises fewer side effects
A medicine that sidesteps the brain's dopamine receptors to reach different targets represents a new approach to ...